# Nandini Piramal

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/nandini-piramal
Canonical HTML page: https://gethealthbrief.com/entity/nandini-piramal

## Recent coverage (1 stories)

### Piramal Pharma Posts ₹8,869 Cr Revenue as 66% Comes from Regulated Markets
2026-07-27 06:56:45 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

Piramal Pharma's FY2026 results reveal a global healthcare manufacturing giant with 66% of its ₹8,869 crore revenue from stringent regulated markets. The company's 17 facilities and 100-country reach underscore its role in ensuring medicine quality and supply chain resilience, directly impacting patient outcomes worldwide.
Full story: https://gethealthbrief.com/story/piramal-pharma-fy2026-revenue-regulated-markets

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.